Clinical trial
Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer
NCT00429182 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00429182 |
|---|---|
| Title | Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer |
| Official title | Phase II Study of Purging of Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer Patients |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Metastatic Breast Carcinoma, Invasive Breast Carcinoma |
| Intervention type | Drug, Procedure |
| Interventions | Carboplatin, Cyclophosphamide, Thiotepa, Stem Cell Transplant |
| Enrollment | 32 |
| Start date | Jun 1, 2007 |
| Primary completion | Feb 1, 2012 |
| Completion | Feb 1, 2012 |
| First posted | Jan 31, 2007 |
| Last update posted | Apr 10, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: